After positive study results, metformin-based anti-diabetic medication from Merck has received a label extension for use throughout pregnancy. Find out more.

A new action plan for rare diseases has been published by the Department of Health and Social Care to mark Rare Diseases Day.

GOLD showcases some standout apps created, or harnessed by, the pharma industry.

Sanofi and GSK are seeking regulatory approval for their adjuvanted protein-based COVID-19 vaccine, as a primary two-dose series and booster dose.

GOLD reviews the top stories in health technology from the past few months, highlighting how tech is changing treatment landscapes and patient experiences.

Pharmaceutical R&D saw sustained growth in clinical trial activity and a record number of novel active substances launched in 2021, according to a new report from IQVIA.

Patient adherence is the focus of a new project launched by the Innovative Medicines Initiative (IMI) and led by Pfizer.

Queen’s University Belfast has entered into a collaboration and licensing agreement with Ipsen to research, develop, manufacture and commercialise FLIP inhibitors.